Production (Stage)
BioRestorative Therapies, Inc.
BRTX
$1.66
$0.063.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -140.17% | 28.99% | -122.89% | 29.44% | 69.00% |
| Total Depreciation and Amortization | 21.31% | 18.03% | 14.73% | 14.94% | 8.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 650.49% | -256.29% | 85.75% | -53.12% | -92.99% |
| Change in Net Operating Assets | 93.44% | -31.37% | 22.96% | -31.80% | -509.87% |
| Cash from Operations | -19.89% | -47.85% | -44.11% | -45.31% | 2.58% |
| Capital Expenditure | -- | 82.29% | -391.60% | -21.72% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 148.77% | 10,539.19% | 10,687.23% | 254.73% | -289.60% |
| Cash from Investing | 148.03% | 1,907.31% | 4,477.57% | 263.03% | -294.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -85.60% | -100.00% | -67.89% | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 546.32% | -- | -- | -- | -- |
| Cash from Financing | -85.47% | -251.99% | -100.00% | -103.11% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 149.69% | 40.77% | -216.78% | 2,174.24% | 70.54% |